AHR and colorectal cancer: Subsequently, TDO2 activates the Kyn-AhR pathway, enhances glycolysis, promotes tumor cell proliferation, and secretes CXCL5 to attract immunogenic tumor-associated macrophages into the tumor microenvironment, thereby suppressing tumor immunity and influencing the progression of colorectal cancer [131].